StockNews.com began coverage on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Free Report) in a report published on Thursday. The firm issued a sell rating on the stock. Several other equities analysts have also commented on ZYNE. HC Wainwright lowered Zynerba Pharmaceuticals from a buy rating to a neutral rating in a research note on Tuesday, […]
StockNews.com assumed coverage on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a sell rating on the stock. ZYNE has been the subject of a number of other reports. Canaccord Genuity Group restated a hold rating and issued a $1.11 target price […]
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE – Get Free Report) President Terri B. Sebree sold 12,401 shares of the company’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $1.33, for a total value of $16,493.33. Following the completion of the transaction, the president now directly owns 596,241 shares […]
StockNews.com initiated coverage on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Free Report) in a research note released on Saturday morning. The firm issued a sell rating on the stock. A number of other research firms have also issued reports on ZYNE. LADENBURG THALM/SH SH lowered shares of Zynerba Pharmaceuticals from a buy rating to a […]
Zynerba Pharmaceuticals (NASDAQ:ZYNE) Downgraded to Neutral at LADENBURG THALM/SH SH theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.